UA124184U - METHOD OF CORRECTION OF ASSOCIATED METABOLIC SYNDROME IN PATIENTS WITH HYPERTONIC DISEASE - Google Patents

METHOD OF CORRECTION OF ASSOCIATED METABOLIC SYNDROME IN PATIENTS WITH HYPERTONIC DISEASE

Info

Publication number
UA124184U
UA124184U UAU201710256U UAU201710256U UA124184U UA 124184 U UA124184 U UA 124184U UA U201710256 U UAU201710256 U UA U201710256U UA U201710256 U UAU201710256 U UA U201710256U UA 124184 U UA124184 U UA 124184U
Authority
UA
Ukraine
Prior art keywords
patients
correction
metabolic syndrome
associated metabolic
compliance
Prior art date
Application number
UAU201710256U
Other languages
Ukrainian (uk)
Inventor
Тетяна Анатоліївна Трибрат
Юрій Михайлович Казаков
Світлана Володимирівна Шуть
Original Assignee
Вищий Державний Навчальний Заклад України "Українська Медична Стоматологічна Академія"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Вищий Державний Навчальний Заклад України "Українська Медична Стоматологічна Академія" filed Critical Вищий Державний Навчальний Заклад України "Українська Медична Стоматологічна Академія"
Priority to UAU201710256U priority Critical patent/UA124184U/en
Publication of UA124184U publication Critical patent/UA124184U/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Спосіб корекції асоційованого метаболічного синдрому у хворих на гіпертонічну хворобу включає оцінку рівня комплаєнсу. Призначають раціональну комбінацію антигіпертензивних лікарських засобів у складі базової комплексної терапії залежно від рівня прихильності комплаєнсу. Оцінка рівня комплаєнсу здійснюється кожні 6 місяців від початку лікування.The method of correction of associated metabolic syndrome in patients with hypertension involves assessment of the level of compliance. Prescribe a rational combination of antihypertensive drugs as part of basic complex therapy, depending on the level of adherence to compliance. Compliance assessment is performed every 6 months from the start of treatment.

UAU201710256U 2017-10-23 2017-10-23 METHOD OF CORRECTION OF ASSOCIATED METABOLIC SYNDROME IN PATIENTS WITH HYPERTONIC DISEASE UA124184U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201710256U UA124184U (en) 2017-10-23 2017-10-23 METHOD OF CORRECTION OF ASSOCIATED METABOLIC SYNDROME IN PATIENTS WITH HYPERTONIC DISEASE

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201710256U UA124184U (en) 2017-10-23 2017-10-23 METHOD OF CORRECTION OF ASSOCIATED METABOLIC SYNDROME IN PATIENTS WITH HYPERTONIC DISEASE

Publications (1)

Publication Number Publication Date
UA124184U true UA124184U (en) 2018-03-26

Family

ID=61730680

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201710256U UA124184U (en) 2017-10-23 2017-10-23 METHOD OF CORRECTION OF ASSOCIATED METABOLIC SYNDROME IN PATIENTS WITH HYPERTONIC DISEASE

Country Status (1)

Country Link
UA (1) UA124184U (en)

Similar Documents

Publication Publication Date Title
CY1124135T1 (en) DOSAGE FORMS FOR THE TREATMENT OF ROMRE'S DISEASE
CY1121826T1 (en) CARBINDOPA AND L-DOPA PRODRUGS AND THEIR USE IN THE TREATMENT OF PARKINSON'S DISEASE
MX2023012450A (en) Esketamine for the treatment of depression.
JP2015057451A5 (en)
CL2018001677A1 (en) Treatment of fabry disease in patients not treated and previously treated with ert
EA201791333A1 (en) GLUCAGON DERIVATIVES WITH IMPROVED STABILITY
CY1121474T1 (en) COMBINATION OF IMMEDIATE ACTION AGENTS AND RIBABIRIN FOR THE TREATMENT OF HCV PATIENTS
HRP20201069T1 (en) Administration of tasimelteon under fasted conditions
EA201691918A1 (en) PHARMACEUTICAL COMPOSITIONS OF KINAZ INHIBITOR KINAZ OF THE RAF FAMILY, METHODS OF THEIR PRODUCTION AND METHODS OF THEIR USE
EA202090242A1 (en) TREATMENT OF FABRY DISEASE IN FZT-NAIVE AND FZT-TREATED PATIENTS
TR201819662T4 (en) Orally dispersible film composition containing enalapril for the treatment of childhood hypertension.
EA202091112A1 (en) SOCRYSTALS, PHARMACEUTICAL COMPOSITIONS BASED ON THEIR BASED AND METHODS OF TREATMENT FOR THEIR APPLICATION
UA124184U (en) METHOD OF CORRECTION OF ASSOCIATED METABOLIC SYNDROME IN PATIENTS WITH HYPERTONIC DISEASE
EA202090028A1 (en) METHODS FOR REDUCING OR PREVENTING CARDIOVASCULAR EVENTS IN PATIENTS WITH TYPE II DIABETES
EA202091446A1 (en) METHODS FOR TREATMENT OF CHRONIC INFLAMMATORY DISEASES
RU2013135325A (en) METHOD FOR CORRECTION AND PREVENTION OF METEOPATHIC REACTIONS IN PATIENTS WITH ARTERIAL HYPERTENSION
UA116484U (en) METHOD OF TREATMENT OF HYPERTENSION WITH METABOLIC SYNDROME
UA107947U (en) METHOD OF COMPLEX TREATMENT OF PATIENTS WITH DEGENERATION OF THE MACULAS IN CHRONIC EARLY ENTRY
EA201991119A1 (en) PHARMACEUTICAL COMPOSITION, METHODS OF TREATMENT AND ITS APPLICATION
RU2013148465A (en) METHOD FOR CORRECTION OF INSULIN RESISTANCE
Takakuwa Increased AST and ALT: case report
UA83410U (en) Method for treatment of patients with chronic pancreatitis with ischemic heart disease at congestive heart failure
RU2013126574A (en) METHOD FOR NIGHT FOOD SYNDROME CORRECTION IN PATIENTS WITH ANXIETY-DEPRESSIVE DISORDERS
UA117569U (en) METHOD OF TREATMENT OF HYPERTONIC DISCIRCULATORY ENCEPHALOPATHY
UA120109U (en) METHOD OF ASSESSMENT OF EFFICIENCY OF CHRONIC HEART FAILURE THERAPY BY VEGETABLE REGULATION INDICATORS